Cerilliant introduces certified Snap-N-Spike® solutions of the anticonvulsant internal standards Tiagabine-D6 HCl, Retigabine-D4, and Valproic acid-D6.
|
Retigabine-D4, 100 ug/mL, 1 mL
|
R-019
|
100 µg/mL in Acetonitrile
An internal standard and Certified Spiking Solution® suitable for quantitation of retigabine levels in urine or other matrices by LC/MS or GC/MS for testing applications in clinical toxicology, forensic analysis, urine drug testing, medication monitoring, or pharmaceutical research. Retigabine, also known as ezogabine, is a new antiepileptic drug developed for treatment of partial seizures. The drug is marketed under the trade names Potiga® in the US and Trobalt® in the EU.
|
|
|
|
Tiagabine-D6 HCl,
|
T-082
|
100 µg/mL (as free base) in Methanol
A Certified Spiking Solution® suitable for use as an internal standard in LC/MS or GC/MS tiagabine testing methods for clinical toxicology, forensic analysis, urine drug testing, medication monitoring, or pharmaceutical research applications. Tiagabine, marketed as the antiepileptic drug Gabitril®, is used in the treatment of anxiety disorders and neuropathic path including fibromyalgia. The drug has also been approved by US FDA as an adjunctive treatment for partial seizures in ages 12 and up.
|
|
|
|
Valproic Acid-D6, 1.0 mg/mL
|
V-029
|
1.0 mg/mL in Methanol
An internal standard and Certified Spiking Solution® suitable for quantitation of valproic acid levels in urine or other matrices by LC/MS or GC/MS for testing applications in clinical toxicology, forensic analysis, medication monitoring, urine drug testing, or therapeutic drug monitoring. Valproic acid, sold under trade names such as Depakote, Valparin, or Stavzor, is an antiepileptic drug and mood stabilizer. The drug is prescribed for treatment of epilepsy, bipolar disorder, migraine headaches, and depression.
|
|
|